Stock Award Plans and Stock-Based Compensation - Schedule of Stock Options Granted (Details) - Stock Options [Member] - USD ($)		12 Months Ended
Jan. 01, 2023	Dec. 31, 2024	Dec. 31, 2023
Stock Award Plans and Stock-Based Compensation - Schedule of Stock Options Granted (Details) [Line Items]
Number of Shares, Granted		55,434	1,089
Weighted Average Exercise Price, Granted		$ 117.5	$ 4,677.36
Number of Shares, Exercised		(371)
Weighted Average Exercise Price, Exercised		$ 0.25
Number of Shares, Expired		(3)
Weighted Average Exercise Price, Expired		$ 700
Number of Shares, Forfeitures		(8,526)	(58)
Weighted Average Exercise Price, Forfeitures		$ 484	$ 4,901.42
Number of Shares, Outstanding Ending Balance	3,615	51,185	4,646
Weighted Average Exercise Price, Outstanding Ending Balance	$ 4,425.28	$ 455	$ 4,481.3
Weighted Average Remaining Life (Years), Outstanding Ending Balance	7 years 8 months 12 days	9 years 3 months 18 days	6 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding Ending Balance
Number of Shares, Legacy Inpixon stock options from merger		5
Weighted Average Exercise Price, Legacy Inpixon stock options from merger		$ 16,917.5
Number of Shares, Exercisable		3,803
Weighted Average Exercise Price, Exercisable		$ 3,330
Weighted Average Remaining Life (Years), Exercisable		7 years 8 months 12 days
Aggregate Intrinsic Value, Exercisable

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.